SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Augustin HG, Koh GY, Thurston G, Alitalo, K. 2009. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10: 165177.
  • Bany BM, Cross JC. 2006. Post-implantation mouse conceptuses produce paracrine signals that regulate the uterine endometrium undergoing decidualization. Dev Biol 294: 445456.
  • Bonagura TW, Aberdeen GW, Babischkin JS, Koos RD, Pepe GJ, Albrecht ED. 2010. Divergent regulation of angiopoietin-1 and −2, Tie-2, and thrombospondin-1 expression by estrogen in the baboon endometrium. Mol Reprod Dev 77: 430438.
  • Chakraborty I, Das SK, Dey SK. 1995. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation. J Endocrinol 147: 339352.
  • Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, Wang H. 2004. Molecular cues to implantation. Endocr Rev 25: 341373.
  • Eklund L, Olsen BR. 2006. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 312: 630641.
  • Geva E, Ginzinger DG, Zaloudek CJ, Moore DH, Byrne A, Jaffe RB. 2002. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 87: 42134224.
  • Hirchenhain J, Huse I, Hess A, Bielfeld P, De BF, Krussel JS. 2003. Differential expression of angiopoietins 1 and 2 and their receptor Tie-2 in human endometrium. Mol Hum Reprod 9: 663669.
  • Holash J, Wiegand SJ, Yancopoulos GD. 1999. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18: 53565362.
  • Johnson ML, Grazul-Bilska AT, Redmer DA, Reynolds LP. 2006. Effects of estradiol-17beta on expression of mRNA for seven angiogenic factors and their receptors in the endometrium of ovariectomized (OVX) ewes. Endocrine 30: 333342.
  • Klauber N, Rohan RM, Flynn E, D'Amato RJ. 1997. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat Med 3: 443446.
  • Krikun G, Sakkas D, Schatz F, Buchwalder L, Hylton D, Tang C, Lockwood CJ. 2004. Endometrial angiopoietin expression and modulation by thrombin and steroid hormones: a mechanism for abnormal angiogenesis following long-term progestin-only contraception. Am J Pathol 164: 21012107.
  • Krikun G, Schatz F, Finlay T, Kadner S, Mesia A, Gerrets R, Lockwood CJ. 2000. Expression of angiopoietin-2 by human endometrial endothelial cells: regulation by hypoxia and inflammation. Biochem Biophys Res Commun 275: 159163.
  • Lédée N, Dubanchet S, Lombroso R, Ville Y, Chaouat G. 2006. Downregulation of human endometrial IL-18 by exogenous ovarian steroids. Am J Reprod Immunol 56: 119123.
  • Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K, Licence D, Bowen JM, Gardner L, King A, Loke YW, Smith SK. 2001. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 86: 18231834.
  • Ma H, Zhu G. 2007. Expression of angiopoietin-1/-2 in the process of mouse embryo implantation. J Huazhong Univ Sci Technolog Med Sci 27: 200202.
  • Ma W, Tan J, Matsumoto H, Robert B, Abrahamson DR, Das SK, Dey SK. 2001. Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus. Mol Endocrinol 15: 19831992.
  • Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 5560.
  • Matsumoto H, Ma WG, Daikoku T, Zhao X, Paria BC, Das SK, Trzaskos JM, Dey SK. 2002. Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice. J Biol Chem 277: 2926029267.
  • Matsumoto H, Sato E. 2006. Uterine angiogenesis during implantation and decidualization in mice. Reprod Med Biol 5: 8186.
  • Rabbani ML, Rogers PA. 2001. Role of vascular endothelial growth factor in endometrial vascular events before implantation in rats. Reproduction 122: 8590.
  • Rockwell LC, Pillai S, Olson CE, Koos RD. 2002. Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod 67: 18041810.
  • Schiessl B, Innes BA, Bulmer JN, Otun HA, Chadwick TJ, Robson SC, Lash GE. 2009. Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta 30: 7987.
  • Sharkey AM, Catalano R, Evans A, Charnock-Jones DS, Smith SK. 2005. Novel antiangiogenic agents for use in contraception. Contraception 71: 263271.
  • Torry DS, Leavenworth J, Chang M, Maheshwari V, Groesch K, Ball ER, Torry RJ. 2007. Angiogenesis in implantation. J Assist Reprod Genet 24: 303315.
  • Wakui S, Yokoo K, Muto T, Suzuki Y, Takahashi H, Furusato M, Hano H, Endou H, Kanai Y. 2006. Localization of Ang-1, −2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis. Lab Invest 86: 11721184.
  • Wang H, Dey SK. 2006. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet 7: 185199.
  • Zhou Y, Bellingard V, Feng KT, McMaster M, Fisher SJ. 2003. Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang-2, PlGF, and VEGF-C9. Dev Biol 263: 114125.